APA (7th ed.) Citation

JS, W., LL, S., D, Y., DM, S., JJ, L., & ZR, C. (2026). Anoctamin 5 as a protective factor in prostate cancer: Insights from WGCNA, machine learning, and experimental analysis, with a focus on the anoctamin family. Translational oncology, 68, 102783. https://doi.org/10.1016/j.tranon.2026.102783

Chicago Style (17th ed.) Citation

JS, Wang, Shao LL, Yao D, Sun DM, Lan JJ, and Cong ZR. "Anoctamin 5 as a Protective Factor in Prostate Cancer: Insights from WGCNA, Machine Learning, and Experimental Analysis, with a Focus on the Anoctamin Family." Translational Oncology 68 (2026): 102783. https://doi.org/10.1016/j.tranon.2026.102783.

MLA (9th ed.) Citation

JS, Wang, et al. "Anoctamin 5 as a Protective Factor in Prostate Cancer: Insights from WGCNA, Machine Learning, and Experimental Analysis, with a Focus on the Anoctamin Family." Translational Oncology, vol. 68, 2026, p. 102783, https://doi.org/10.1016/j.tranon.2026.102783.